Anti-FAR1 monoclonal antibody

Pre-made anti-FAR1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FAR1/FAR1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0832-Ab-1/ GM-Tg-hg-IP0832-Ab-2Anti-Human FAR1 monoclonal antibodyHuman
GM-Tg-rg-IP0832-Ab-1/ GM-Tg-rg-IP0832-Ab-2Anti-Rat FAR1 monoclonal antibodyRat
GM-Tg-mg-IP0832-Ab-1/ GM-Tg-mg-IP0832-Ab-2Anti-Mouse FAR1 monoclonal antibodyMouse
GM-Tg-cynog-IP0832-Ab-1/ GM-Tg-cynog-IP0832-Ab-2Anti-Cynomolgus/ Rhesus macaque FAR1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0832-Ab-1/ GM-Tg-felg-IP0832-Ab-2Anti-Feline FAR1 monoclonal antibodyFeline
GM-Tg-cang-IP0832-Ab-1/ GM-Tg-cang-IP0832-Ab-2Anti-Canine FAR1 monoclonal antibodyCanine
GM-Tg-bovg-IP0832-Ab-1/ GM-Tg-bovg-IP0832-Ab-2Anti-Bovine FAR1 monoclonal antibodyBovine
GM-Tg-equg-IP0832-Ab-1/ GM-Tg-equg-IP0832-Ab-2Anti-Equine FAR1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0832-Ab-1/ GM-Tg-hg-IP0832-Ab-2; GM-Tg-rg-IP0832-Ab-1/ GM-Tg-rg-IP0832-Ab-2;
GM-Tg-mg-IP0832-Ab-1/ GM-Tg-mg-IP0832-Ab-2; GM-Tg-cynog-IP0832-Ab-1/ GM-Tg-cynog-IP0832-Ab-2;
GM-Tg-felg-IP0832-Ab-1/ GM-Tg-felg-IP0832-Ab-2; GM-Tg-cang-IP0832-Ab-1/ GM-Tg-cang-IP0832-Ab-2;
GM-Tg-bovg-IP0832-Ab-1/ GM-Tg-bovg-IP0832-Ab-2; GM-Tg-equg-IP0832-Ab-1/ GM-Tg-equg-IP0832-Ab-2
Products NameAnti-FAR1 monoclonal antibody
Formatmab
Target NameFAR1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FAR1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0832-Ag-1Recombinant multi-species FACR1/ FAR1/ MLSTD2 protein


    Target information

    Target IDGM-IP0832
    Target NameFAR1
    Gene ID84188,67420,293173,699947,476863,101093138,525262,100071555
    Gene Symbol and Synonyms2600011M19Rik,2900034E22Rik,3732409C05Rik,CSPSD,FAR1,MLSTD2,PFCRD,SDR10E1
    Uniprot AccessionQ8WVX9,Q66H50
    Uniprot Entry NameFACR1_HUMAN,FACR1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000197601
    Target ClassificationN/A

    The target: FAR1, gene name: FAR1, also named as MLSTD2, PFCRD, SDR10E1. The protein encoded by this gene is required for the reduction of fatty acids to fatty alcohols, a process that is required for the synthesis of monoesters and ether lipids. NADPH is required as a cofactor in this reaction, and 16-18 carbon saturated and unsaturated fatty acids are the preferred substrate. This is a peroxisomal membrane protein, and studies suggest that the N-terminus contains a large catalytic domain located on the outside of the peroxisome, while the C-terminus is exposed to the matrix of the peroxisome. Studies indicate that the regulation of this protein is dependent on plasmalogen levels. Mutations in this gene have been associated with individuals affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity (PMID: 25439727). A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jan 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.